Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 7.85% ...

The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...

Taxing imports to the US could spell major consequences for health care prices, innovation, and access, as a great amount of ...

The Therapeutic Drug Monitoring Market Industry is expected to grow from 5.06 (USD Billion) in 2024 to 9.5 (USD Billion) by 2035. The Therapeutic Drug Monitoring Market CAGR (growth rate ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

Pfizer’s decision to discontinue development of danuglipron is a big event for the obesity treatment market. As an oral drug, danuglipron ... which is under the industry’s average price ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.